TCL Archive Two Conflicting Studies Presented at ASCO 2013, FDA Called Upon To Sort Through The Data June 28, 2013
TCL Archive Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer July 26, 2002
TCL Archive In Brief: Lepovetsky Heads New NCI Office Of Technology Development; Temporary Now, Maybe Permanent November 27, 1987